Prime Medicine Inc
PRME
ISIN US74168J1016 / Valor 122054714
Prime Medicine Inc
UMushroom community rating:
About company
Prime Medicine Inc is a biotechnology company focused on utilizing their innovative Prime Editing platform to address genetic diseases at their root cause. Their technology aims to replace faulty DNA with correct copies, potentially offering long-lasting cures for patients. Prime Editing is designed to be versatile, precise, and efficient, with the capability to target a wide range of disease-causing mutations across various organisms, organs, and cell types. The company believes that their approach will significantly enhance the impact of gene editing in therapeutic applications.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
707 M
Market cap (USD)
319,518
Daily traded volume (Shares)
3.07 / 2.855
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
